A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome

about

A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome

Item

http://www.wikidata.org/entity/Q58804287

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome

@en

A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome

@nl

type

Item

label

A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome

@en

A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome

@nl

prefLabel

A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome

@en

A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome

@nl

P1476

A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome

@en

P2093

Bláthnaid McCoy

http://www.w3.org/2001/XMLSchema#string

Grace Zhang

http://www.w3.org/2001/XMLSchema#string

Katia Sinopoli

http://www.w3.org/2001/XMLSchema#string

Kenda Alhadid

http://www.w3.org/2001/XMLSchema#string

Kyla McDonald

http://www.w3.org/2001/XMLSchema#string

Laura Wang

http://www.w3.org/2001/XMLSchema#string

Maria Zak

http://www.w3.org/2001/XMLSchema#string

Nadia Kabir

http://www.w3.org/2001/XMLSchema#string

O Carter Snead

http://www.w3.org/2001/XMLSchema#string

Robyn Whitney

http://www.w3.org/2001/XMLSchema#string

P2860

Cannabinoids for epilepsy

Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects

Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

Cannabinoids and Epilepsy.

Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials

Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment.

Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Chemical constituents of marijuana: the complex mixture of natural cannabinoids.

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.

P304

1077-1088

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACN3.621

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30250864

http://www.w3.org/2001/XMLSchema#string

P921

tetrahydrocannabinol

cannabinoids

P932

6144444

http://www.w3.org/2001/XMLSchema#string